Aflac Incorporated (NYSE:AFL) Shares Sold by Trillium Asset Management LLC

Trillium Asset Management LLC reduced its position in Aflac Incorporated (NYSE:AFL) by 1.3% in the 4th quarter, Holdings Channel reports. The firm owned 335,763 shares of the financial services provider’s stock after selling 4,422 shares during the quarter. Trillium Asset Management LLC’s holdings in Aflac were worth $34,731,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in AFL. Whipplewood Advisors LLC acquired a new stake in shares of Aflac in the 4th quarter worth $26,000. Darwin Wealth Management LLC acquired a new stake in shares of Aflac in the 3rd quarter worth $34,000. BankPlus Trust Department acquired a new stake in shares of Aflac in the 4th quarter worth $34,000. Curio Wealth LLC acquired a new stake in shares of Aflac in the 4th quarter worth $36,000. Finally, Raelipskie Partnership acquired a new stake in shares of Aflac in the 3rd quarter worth $38,000. 67.44% of the stock is owned by institutional investors and hedge funds.

Aflac Stock Performance

Shares of Aflac stock opened at $107.27 on Wednesday. The business has a 50-day moving average of $105.60 and a 200 day moving average of $107.65. Aflac Incorporated has a 12 month low of $79.31 and a 12 month high of $115.50. The stock has a market capitalization of $58.63 billion, a price-to-earnings ratio of 11.17, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08.

Aflac (NYSE:AFL) last announced its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, sell-side analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on AFL. Keefe, Bruyette & Woods cut their target price on Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research note on Wednesday, February 12th. Wells Fargo & Company cut their target price on Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 19th. Morgan Stanley raised their price objective on Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Friday, February 28th. JPMorgan Chase & Co. raised their price objective on Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 7th. Finally, Evercore ISI cut their price objective on Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a research report on Wednesday, December 4th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $103.36.

Insider Activity

In other news, EVP Audrey B. Tillman sold 24,744 shares of Aflac stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the transaction, the executive vice president now owns 222,618 shares in the company, valued at approximately $23,018,701.20. This trade represents a 10.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Joseph L. Moskowitz sold 1,000 shares of Aflac stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the transaction, the director now owns 25,393 shares of the company’s stock, valued at $2,733,048.59. The trade was a 3.79 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 55,546 shares of company stock worth $5,863,616. 0.80% of the stock is currently owned by company insiders.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.